Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

77.100
+2.3003.07%
Volume:3.12M
Turnover:238.35M
Market Cap:43.45B
PE:51.11
High:77.500
Open:73.500
Low:73.500
Close:74.800
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.32
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.509
ROE:109.10%
ROA:39.01%
PB:4.47
PE(LYR):51.11
PS:4.64

Loading ...

RemeGen Biotech Shares Rise Over 3% in Late Trading; Telitacicept gMG China Phase III Analysis Results Presented at AANEM Annual Meeting

Stock News
·
Yesterday

Movement Alert|REMEGEN Rises 5.13% in Regular Trading, Biotech Sector Rally Extends Amid Innovative Drug Boom

Market Focus
·
Sep 29

Movement Alert|REMEGEN Falls 5.08% in Regular Trading, Biotech Sector Under Pressure Amid Earnings Sustainability Concerns

Market Focus
·
Sep 24

RemeGen Turns Profitable on Licensing Windfall and Strong Drug Sales; H1 Revenue Jumps to RMB 5.85 Billion

Bulletin Express
·
Sep 23

HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%

Tiger Newspress
·
Sep 21

Movement Alert|REMEGEN Rises 5.35% in Regular Trading, RC148 Lung Cancer Clinical Data Debut at World Lung Cancer Conference Draws Market Attention

Market Focus
·
Sep 21

RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales

Deep News
·
Sep 17

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

Deep News
·
Sep 07

RemeGen Maintains Stable Share Base; Minor A-Share Buyback Adds to Treasury in August 2026

Bulletin Express
·
Sep 04

REMEGEN Discloses Cumulative Buyback of 41,000 A-Shares by End of August

Stock News
·
Sep 02

Executive Director Wang Yuxiao Reduces Stake in Remegen (09995) by 13,500 Shares at Approximately HK$81.54 Each

Stock News
·
Sep 02

Executive Director Wang Yuxiao Reduces Stake in Remegen with Share Sale

Stock News
·
Sep 01

RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability

Simply Wall St.
·
Aug 26

Citi Lifts REMEGEN Price Target to HK$127.7, Keeps Buy/High-Risk Call

Stock News
·
Aug 26

CLSA Raises REMEGEN Price Target to HK$144.8, Reiterates Outperform Rating on Strong Q2 Beat

Stock News
·
Aug 26

HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%

Tiger Newspress
·
Aug 26

Movement Alert|REMEGEN Rises 5.04% in Regular Trading, Interim Results Turn Profitable Amid Biotech Sector Rally

Market Focus
·
Aug 26

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

Stock News
·
Aug 25

Movement Alert|REMEGEN Rises 5.12% in Regular Trading, H1 Earnings Show Turnaround to Profitability with Revenue Surging Over 4x

Market Focus
·
Aug 25